Table III.
Male |
Female |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
No. of events/total no. (%) |
P values | P values | No. of events/total no. (%) |
P values | P values | |||||
Intervention | Control 1 | Control 2 | Intervention | Control 1 | Control 2 | |||||
Overall | 79/242 (32.6) | 43/242 (17.8) | <0.001 | 35/242 (14.5) | <0.001 | 122/243 (50.2) | 64/243 (26.3) | <0.001 | 34/243 (14.0) | <0.001 |
Age group | ||||||||||
20–24 | 9/42 (21.4) | 9/40 (22.5) | 0.91 | 5/39 (12.8) | 0.31 | 13/43 (30.2) | 14/41 (34.1) | 0.70 | 8/45 (17.8) | 0.17 |
25–29 | 18/58 (31.0) | 12/62 (19.4) | 0.14 | 9/58 (15.5) | 0.048 | 35/68 (51.5) | 14/72 (19.4) | <0.001 | 10/65 (15.4) | <0.001 |
30–34 | 26/62 (41.9) | 11/60 (18.3) | 0.005 | 13/65 (20.0) | 0.007 | 31/52 (59.6) | 10/50 (20.0) | <0.001 | 8/53 (15.1) | <0.001 |
35–39 | 26/80 (32.5) | 11/80 (13.8) | 0.005 | 8/80 (10.0) | 0.001 | 43/80 (53.8) | 26/80 (32.5) | 0.007 | 8/80 (10.0) | <0.001 |
P-values compare the preceding control group with the intervention group using χ2 tests.